---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-042572"
form_type: "8-K"
ticker: "ICU"
cik: "0001831868"
company_name: "SeaStar Medical Holding Corp"
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:37:18.847528+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SeaStar Medical Q2 net loss widens to $3.7M; cash at $13K; FDA setback on pediatric device

## Summary
- Net loss $3.7M ($0.25/sh) vs $0.9M ($0.12) in Q2 2022; R&D up to $2.0M, G&A $1.7M.
- Cash only $13K as of June 30; raised $3.3M convertible debt in March, $2.2M in May, $543K note in August.
- FDA HDE application for pediatric SCD-PED not approvable; working with FDA for resubmission.
- Two sites activated for adult NEUTRALIZE-AKI trial; expects SCD-ADULT approval H1 2025, launch H2 2025.
- Business update call on Aug 22, 2023 at 4pm ET.

## SEC filing metadata
- accession: 0000950170-23-042572
- form_type: 8-K
- ticker: ICU
- cik: 0001831868
- company_name: SeaStar Medical Holding Corp
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831868/000095017023042572/0000950170-23-042572-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831868/000095017023042572/icu-20230814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-042572
- JSON: https://secwatch.observer/filing/0000950170-23-042572.json
- Plain text: https://secwatch.observer/filing/0000950170-23-042572.txt

## Key facts
- Earnings Releases
  SeaStar Medical Holding Corp reported financial results for second quarter ended June 30, 2023.
  - Period: second quarter ended June 30, 2023
  - Result: reported results
  source text: On August 14, 2023, SeaStar Medical Holding Corporation (the “Company”) issued a press release announcing its financial condition and results of operations for the fiscal quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831868/000095017023042572/0000950170-23-042572-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.